BCL2 and plasma cell myeloma: Finally, by taking advantage of the large public Multiple Myeloma Research Foundation (MMRF) CoMMpass dataset including MM samples characterized for genome abnormalities, transcriptome, and clinical outcome, we confirmed that BCL2, BMF, PMAIP1, and BCL2L11 expression levels were higher in MMs with t(11;14) than in MMs without t(11;14).